210 related articles for article (PubMed ID: 8203302)
1. The mode of action and the mechanism of resistance to antimalarial drugs.
Foote SJ; Cowman AF
Acta Trop; 1994 Mar; 56(2-3):157-71. PubMed ID: 8203302
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in antimalarial compounds and their patents.
Mital A
Curr Med Chem; 2007; 14(7):759-73. PubMed ID: 17346161
[TBL] [Abstract][Full Text] [Related]
3. The past, present and future of antifolates in the treatment of Plasmodium falciparum infection.
Nzila A
J Antimicrob Chemother; 2006 Jun; 57(6):1043-54. PubMed ID: 16617066
[TBL] [Abstract][Full Text] [Related]
4. Antimalarial drug development and new targets.
Macreadie I; Ginsburg H; Sirawaraporn W; Tilley L
Parasitol Today; 2000 Oct; 16(10):438-44. PubMed ID: 11006476
[TBL] [Abstract][Full Text] [Related]
5. Molecular and physiologic basis of quinoline drug resistance in Plasmodium falciparum malaria.
Roepe PD
Future Microbiol; 2009 May; 4(4):441-55. PubMed ID: 19416013
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of resistance of Plasmodium falciparum to antimalarial drugs.
Hyde JE
Microbes Infect; 2002 Feb; 4(2):165-74. PubMed ID: 11880048
[TBL] [Abstract][Full Text] [Related]
7. Chemoresistance in falciparum malaria.
May J; Meyer CG
Trends Parasitol; 2003 Oct; 19(10):432-5; discussion 435-6. PubMed ID: 14519577
[No Abstract] [Full Text] [Related]
8. Mechanisms of drug resistance in malaria.
Cowman AF
Aust N Z J Med; 1995 Dec; 25(6):837-44. PubMed ID: 8770361
[TBL] [Abstract][Full Text] [Related]
9. The antimalarial triazine WR99210 and the prodrug PS-15: folate reversal of in vitro activity against Plasmodium falciparum and a non-antifolate mode of action of the prodrug.
Kinyanjui SM; Mberu EK; Winstanley PA; Jacobus DP; Watkins WM
Am J Trop Med Hyg; 1999 Jun; 60(6):943-7. PubMed ID: 10403325
[TBL] [Abstract][Full Text] [Related]
10. The molecular basis of antifolate resistance in Plasmodium falciparum: looking beyond point mutations.
Heinberg A; Kirkman L
Ann N Y Acad Sci; 2015 Apr; 1342(1):10-8. PubMed ID: 25694157
[TBL] [Abstract][Full Text] [Related]
11. Antimalarial drugs: modes of action and mechanisms of parasite resistance.
Müller IB; Hyde JE
Future Microbiol; 2010 Dec; 5(12):1857-73. PubMed ID: 21155666
[TBL] [Abstract][Full Text] [Related]
12. Comparative folate metabolism in humans and malaria parasites (part I): pointers for malaria treatment from cancer chemotherapy.
Nzila A; Ward SA; Marsh K; Sims PF; Hyde JE
Trends Parasitol; 2005 Jun; 21(6):292-8. PubMed ID: 15922251
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of resistance of malaria parasites to antifolates.
Gregson A; Plowe CV
Pharmacol Rev; 2005 Mar; 57(1):117-45. PubMed ID: 15734729
[TBL] [Abstract][Full Text] [Related]
14. Quinolines and artemisinin: chemistry, biology and history.
Bray PG; Ward SA; O'Neill PM
Curr Top Microbiol Immunol; 2005; 295():3-38. PubMed ID: 16265885
[TBL] [Abstract][Full Text] [Related]
15. Quinoline-resistance reversing agents for the malaria parasite Plasmodium falciparum.
van Schalkwyk DA; Egan TJ
Drug Resist Updat; 2006; 9(4-5):211-26. PubMed ID: 17064951
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of efflux of quinolines as new therapeutic strategy in malaria.
Henry M; Alibert S; Rogier C; Barbe J; Pradines B
Curr Top Med Chem; 2008; 8(7):563-78. PubMed ID: 18473883
[TBL] [Abstract][Full Text] [Related]
17. Molecular approaches to the spreading problem of drug resistant malaria.
Plowe CV; Wellems TE
Adv Exp Med Biol; 1995; 390():197-209. PubMed ID: 8718614
[No Abstract] [Full Text] [Related]
18. Mode of action and mechanisms of resistance for antimalarial drugs.
Olliaro P
Pharmacol Ther; 2001 Feb; 89(2):207-19. PubMed ID: 11316521
[TBL] [Abstract][Full Text] [Related]
19. Quinoline-containing antimalarials--mode of action, drug resistance and its reversal. An update with unresolved puzzles.
Ginsburg H; Krugliak M
Biochem Pharmacol; 1992 Jan; 43(1):63-70. PubMed ID: 1734899
[TBL] [Abstract][Full Text] [Related]
20. How to tackle antimalarial resistance?
Leroy D
EMBO Mol Med; 2017 Feb; 9(2):133-134. PubMed ID: 28028013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
